Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05626452 · ClinicalTrials.gov registry record · NA
PrEP Optimization Among Women to Enhance Retention and Uptake
A NA study of PrEP Uptake, sponsored by University of Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 680
- Enrollment target
- 1
- Study location
NCT05626452: Recruiting NA study of PrEP Uptake, sponsored by University of Chicago.
NCT05626452 is a NA study of PrEP Uptake that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 680 participants, above the 229-participant average among 3 other PrEP Uptake trials with a reported enrollment target (197% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05626452, a NA study of PrEP Uptake, is actively recruiting participants, sponsored by University of Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 680 participants
- Enrollment target
- 1
- Study location
Study Summary
Black women experience one of the highest incidences of HIV among all subpopulations in the United States, but pre-exposure prophylaxis (PrEP) use among Black cisgender women is very limited. The investigators will implement four strategies (provider training, patient education, EMR optimization, and PrEP navigation) at 12 community health clinics in the Midwest and South. The investigators predict that PrEP use and other related outcomes will improve for participants after the intervention period.
Primary Outcome
Number of participants initiating PrEP
Conditions Studied
Interventions
- BEHAVIORAL Provider training
- BEHAVIORAL PrEP Education
- OTHER EMR Optimization
- OTHER PrEP Navigation
- OTHER Provider Audit and Feedback
Study Locations (1)
Illinois
- University of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 680 participants |
| Start Date | 2023-08-10 |
| Est. Completion | 2026-06 |
| Phase | NA |
What NCT05626452 shows while recruiting
NCT05626452 is an interventional study that assigns participants to a tested intervention. The registered 680 participants enrollment target is mid-sized for trials with a published cap, above the 229-participant average among 3 other PrEP Uptake trials with a reported enrollment target (197% higher).
The record links to 1 condition, with PrEP Uptake appearing as the primary indexed condition, and to 5 interventions - of which Provider training is the first listed.
NCT05626452 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05626452 about?
NCT05626452 is a clinical study titled "PrEP Optimization Among Women to Enhance Retention and Uptake". Black women experience one of the highest incidences of HIV among all subpopulations in the United States, but pre-exposure prophylaxis (PrEP) use among Black cisgender women is very limited. The investigators will implement four strategies (provider training, patient education, EMR optimization, an...
What is the current status of trial NCT05626452?
This trial is currently recruiting. It is a NA study. The enrollment target is 680 participants. The study started on 2023-08-10. Estimated completion is 2026-06.
What conditions does trial NCT05626452 study?
This clinical trial studies the following conditions: PrEP Uptake.
What interventions are being tested in trial NCT05626452?
The interventions under investigation include: Provider training (BEHAVIORAL), PrEP Education (BEHAVIORAL), EMR Optimization (OTHER), PrEP Navigation (OTHER), Provider Audit and Feedback (OTHER).
Who is sponsoring clinical trial NCT05626452?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05626452 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PrEP Uptake
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
PrOTECT AL: PrEP Optimization Through Enhanced Continuum Tracking
RECRUITING · NA
-
P3 Trial: Estimating the Impact of a Multilevel, Multicomponent Intervention to Increase Uptake of HIV Testing and Biomedical HIV Prevention Among African-American/Black Gay, Bisexual, and Same-gender Loving Men
RECRUITING · NA
-
Pre-exposure Prophylaxis Accessibility Research and Evaluation 2
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03501706 · 680 participants · NA
An Assessment of Cognitive Improvement Training Among Mid-life Individuals
- NCT05753748 · 680 participants · NA
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
- NCT05952141 · 680 participants · NA
Strategies to Close the Gap From Cervical Cancer Diagnosis to Treatment in Botswana
- NCT06112314 · 680 participants · Phase 3
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI